About Lotus Therapeutics

At Lotus Therapeutics, our mission is to revolutionize access to life-changing medications by keeping patients at the heart of everything we do. Founded in 2024, we aim to address unmet medical needs through innovative therapies, all while maintaining competitive pricing to ensure that advancements are accessible to those who need them most. As a forward-thinking generics company, we focus on developing complex and unique formulations that expand access and choice for both patients and healthcare providers.

Beyond our work in generics, we specialize in managing post-Loss of Exclusivity (LOE) assets. These assets come with distinct challenges, particularly considering recent legislative shifts and increased market sophistication. With over 40 years of experience and 70+ successful product launches across global markets—including ANDAs, authorized generics, and branded products—we are equipped to simplify operations and maximize the value of mature portfolios for our partners, fully managed by our expert team.

Lotus Therapeutics was founded by visionary industry leaders including those behind Speranza Therapeutics, pioneers in medical device therapies for opioid addiction. This legacy of innovation and meaningful impact is embedded in our DNA and continues to guide our forward-thinking approach to healthcare. Though our journey is just beginning, our commitment to delivering affordable, high-quality therapies remains steadfast.

Together with our partners, we are shaping a future where healthcare is more accessible, affordable, and effective for everyone. At Lotus, we are redefining what it means to provide transformative therapies in an ever-evolving world.

Interested in partnering with us? Email us at info@lotusthera.com.